Paperpal Prime Logo

Cancer Medicine : Impact Factor & More

eISSN: 2045-7634pISSN: 2045-7634
JournalOpen Access

Key Metrics

CiteScore
6.7
Eigenfactor
0.01 - 0.05
Impact Factor
< 5
Scite Index
0.87 5-Year SI
SJR
Q3Oncology
SNIP
1.21
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Cancer Medicine

Cancer Medicine Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher WILEY
Language English
Frequency Monthly
Article Processing ChargesEUR 2300 | GBP 1950 | USD 3025
Publication Time19
Editorial Review ProcessDouble anonymous peer review
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2012
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 19
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessDouble anonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY
OA statementVisit website
View less

Planning to publish in Cancer Medicine ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Cancer Medicine

Associations Between Circulating Metabolites and Skin Cancer: A Bidirectional Two\u2010Sample Mendelian Randomization Study
  • 1 Oct 2026
  • Cancer Medicine
Correction to \u201cImmune\u2010Related Adverse Events and Therapeutic Outcomes After Stopping Immune Checkpoint Inhibitors due to Toxicity Among Patients With Metastatic Melanoma (University Hospitals Sussex)\u201d
  • 1 Oct 2026
  • Cancer Medicine
Extranodal Organ Involvement in Chronic Lymphocytic Leukemia: Clinical Features and Outcomes With Bruton Tyrosine Kinase and BCL\u20102 Inhibitors
  • 1 Oct 2026
  • Cancer Medicine
Integrated scRNA\u2010Seq and Spatial Transcriptomics Reveal CHPF and GPC1 as Markers of Cancer\u2010Associated Fibroblast\u2013Dominant Domains in Colorectal Cancer
  • 1 Oct 2026
  • Cancer Medicine
Combined Active Bone Marrow\u2010Sparing Radiotherapy and Prophylactic PEG\u2010rhG\u2010CSF to Reduce Severe Neutropenia During Platinum\u2010Doublet Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer: A Phase II Trial
  • 1 Oct 2026
  • Cancer Medicine
Apparent Survival Benefit of Postoperative Radioactive Iodine in Lymph Node-Positive Papillary Thyroid Carcinoma: A Negative-Control Analysis for Unmeasured Confounding.
  • 1 Oct 2026
  • Cancer medicine
Associations Between Circulating Metabolites and Skin Cancer: A Bidirectional Two\u2010Sample Mendelian Randomization Study
  • 1 Oct 2026
  • Cancer Medicine
Correction to \u201cImmune\u2010Related Adverse Events and Therapeutic Outcomes After Stopping Immune Checkpoint Inhibitors due to Toxicity Among Patients With Metastatic Melanoma (University Hospitals Sussex)\u201d
  • 1 Oct 2026
  • Cancer Medicine
Extranodal Organ Involvement in Chronic Lymphocytic Leukemia: Clinical Features and Outcomes With Bruton Tyrosine Kinase and BCL\u20102 Inhibitors
  • 1 Oct 2026
  • Cancer Medicine
Integrated scRNA\u2010Seq and Spatial Transcriptomics Reveal CHPF and GPC1 as Markers of Cancer\u2010Associated Fibroblast\u2013Dominant Domains in Colorectal Cancer
  • 1 Oct 2026
  • Cancer Medicine
Combined Active Bone Marrow\u2010Sparing Radiotherapy and Prophylactic PEG\u2010rhG\u2010CSF to Reduce Severe Neutropenia During Platinum\u2010Doublet Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer: A Phase II Trial
  • 1 Oct 2026
  • Cancer Medicine
Apparent Survival Benefit of Postoperative Radioactive Iodine in Lymph Node-Positive Papillary Thyroid Carcinoma: A Negative-Control Analysis for Unmeasured Confounding.
  • 1 Oct 2026
  • Cancer medicine

FAQs on Cancer Medicine